{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:04:42Z","timestamp":1794377082565,"version":"4.9.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41409-018-0105-9","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T12:43:29Z","timestamp":1517316209000},"page":"873-879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: A National Cancer Database Study"],"prefix":"10.1038","volume":"53","author":[{"given":"Vijaya Raj","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"105_CR1","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2009.813","volume":"301","author":"J Koreth","year":"2009","unstructured":"Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301:2349\u201361.","journal-title":"JAMA"},{"key":"105_CR2","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, et al. NCCN Clinical Practice Guidelines in Oncology. Acute Myeloid Leukemia version 3. 2017. Available at \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf\n                    \n                  . Accessed on 6 Oct 2017."},{"key":"105_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"105_CR4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97:1916\u201324.","journal-title":"Haematologica"},{"key":"105_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40258-013-0032-2","volume":"11","author":"J Meyers","year":"2013","unstructured":"Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11:275\u201386.","journal-title":"Appl Health Econ Health Policy"},{"key":"105_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1055-9965.EPI-14-0963","volume":"24","author":"MI Patel","year":"2015","unstructured":"Patel MI, Ma Y, Mitchell B, Rhoads KF. How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia? Cancer Epidemiol Biomark Prev. 2015;24:344\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"105_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/leu.2015.188","volume":"30","author":"AG Dinmohamed","year":"2016","unstructured":"Dinmohamed AG, Visser O, van Norden Y, Blijlevens NM, Cornelissen JJ, Huls GA, et al. Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012. Leukemia. 2016;30:24\u201331.","journal-title":"Leukemia"},{"key":"105_CR8","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1002\/cncr.26033","volume":"117","author":"G Juliusson","year":"2011","unstructured":"Juliusson G, Karlsson K, Lazarevic V, Wahlin A, Brune M, Antunovic P, et al. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. Cancer. 2011;117:4238\u201346.","journal-title":"Cancer"},{"key":"105_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/bmt.2012.95","volume":"48","author":"J Pidala","year":"2013","unstructured":"Pidala J, Craig BM, Lee SJ, Majhail N, Quinn G, Anasetti C. Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:63\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"105_CR10","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","volume":"20","author":"O Ringden","year":"2014","unstructured":"Ringden O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, et al. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant. 2014;20:1777\u201384.","journal-title":"Biol Blood Marrow Transplant"},{"key":"105_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/ctr.12421","volume":"28","author":"C Pandya","year":"2014","unstructured":"Pandya C, Hashmi S, Khera N, Gertz MA, Dispenzieri A, Hogan W, et al. Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma. Clin Transplant. 2014;28:1084\u201391.","journal-title":"Clin Transplant"},{"key":"105_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3109\/10428194.2014.941834","volume":"56","author":"N Khera","year":"2014","unstructured":"Khera N, Chang YH, Slack J, Fauble V, Leis JF, Noel P, et al. Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2014;56:987\u201392.","journal-title":"Leuk Lymphoma"},{"key":"105_CR13","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1200\/JCO.2013.50.2567","volume":"31","author":"R Mawad","year":"2013","unstructured":"Mawad R, Gooley TA, Sandhu V, Lionberger J, Scott B, Sandmaier BM, et al. Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission. J Clin Oncol. 2013;31:3883\u20138.","journal-title":"J Clin Oncol"},{"key":"105_CR14","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1200\/JCO.2017.73.6728","volume":"35","author":"LSG Ostgard","year":"2017","unstructured":"Ostgard LSG, Norgaard M, Medeiros BC, Friis LS, Schoellkopf C, Severinsen MT, et al. Effects of education and income on treatment and outcome in patients with acute myeloid leukemia in a tax-supported health care system: A National Population-based Cohort Study. J Clin Oncol. 2017;35:3678\u201387.","journal-title":"J Clin Oncol"},{"key":"105_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbmt.2016.03.008","volume":"22","author":"VR Bhatt","year":"2016","unstructured":"Bhatt VR, Loberiza FR Jr, Schmit-Pokorny K, Lee SJ. Time to insurance approval in private and public payers does not influence survival in patients who undergo hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22:1117\u201324.","journal-title":"Biol Blood Marrow Transplant"},{"key":"105_CR16","doi-asserted-by":"publisher","unstructured":"Bhatt VR, Chen B, Lee S, Hematopoietic cell transplantation (HCT) in older patients with acute myeloid leukemia (AML). J Clin Oncol. 2016;34(15_suppl):e18026. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.34.15_suppl.e18026\n                    \n                  .","DOI":"10.1200\/JCO.2016.34.15_suppl.e18026"},{"key":"105_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ajh.24767","volume":"92","author":"VR Bhatt","year":"2017","unstructured":"Bhatt VR, Shostrom V, Giri S, Gundabolu K, Monirul Islam KM, Appelbaum FR, et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am J Hematol. 2017;92:764\u201371.","journal-title":"Am J Hematol"},{"key":"105_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-514","volume":"10","author":"F Bhayat","year":"2010","unstructured":"Bhayat F, Das-Gupta E, Hubbard R. Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study. BMC Cancer. 2010;10:514.","journal-title":"BMC Cancer"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0105-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:27Z","timestamp":1684617087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0105-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0105-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"13 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}